These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16365413)

  • 1. Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin.
    Margalit A; Sheikhet HM; Carmi Y; Berko D; Tzehoval E; Eisenbach L; Gross G
    J Immunol; 2006 Jan; 176(1):217-24. PubMed ID: 16365413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules.
    Berko D; Carmi Y; Cafri G; Ben-Zaken S; Sheikhet HM; Tzehoval E; Eisenbach L; Margalit A; Gross G
    J Immunol; 2005 Feb; 174(4):2116-23. PubMed ID: 15699142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
    Carmon L; El-Shami KM; Paz A; Pascolo S; Tzehoval E; Tirosh B; Koren R; Feldman M; Fridkin M; Lemonnier FA; Eisenbach L
    Int J Cancer; 2000 Feb; 85(3):391-7. PubMed ID: 10652432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo CTL immunity can be elicited by OVA-linker-beta2m fusion protein.
    Qian L; Qian GX
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):547-52. PubMed ID: 12198554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity.
    Cafri G; Sharbi-Yunger A; Tzehoval E; Alteber Z; Gross T; Vadai E; Margalit A; Gross G; Eisenbach L
    Mol Ther; 2015 Aug; 23(8):1391-1400. PubMed ID: 25997427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of P1A35-43/beta2m fusion protein and co-stimulatory molecule CD80 elicits effective anti-tumor immunity in the P815 mouse mastocytoma tumor model.
    Zhang X; Mei W; Zhang L; Yu H; Zhao X; Fan X; Qian G; Ge S
    Oncol Rep; 2009 Nov; 22(5):1213-20. PubMed ID: 19787242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
    Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
    Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA; Barber BH
    J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximizing immune responses: the effects of covalent peptide linkage to beta-2-microglobulin.
    Bauer SM; Williams MA; Howell AP; Schwarz E; Smith ES; Zauderer M
    Oncol Res; 2008; 17(5):205-16. PubMed ID: 18980017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.
    Bellone M; Cantarella D; Castiglioni P; Crosti MC; Ronchetti A; Moro M; Garancini MP; Casorati G; Dellabona P
    J Immunol; 2000 Sep; 165(5):2651-6. PubMed ID: 10946294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses.
    Lu J; Higashimoto Y; Appella E; Celis E
    J Immunol; 2004 Apr; 172(7):4575-82. PubMed ID: 15034075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells.
    Matsunaga Y; Fukuma D; Hirata S; Fukushima S; Haruta M; Ikeda T; Negishi I; Nishimura Y; Senju S
    J Immunol; 2008 Nov; 181(9):6635-43. PubMed ID: 18941254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
    Zügel U; Schoel B; Kaufmann SH
    J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
    Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
    Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules.
    Tafuro S; Meier UC; Dunbar PR; Jones EY; Layton GT; Hunter MG; Bell JI; McMichael AJ
    Eur J Immunol; 2001 Feb; 31(2):440-9. PubMed ID: 11180108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
    Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
    J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene.
    Cafri G; Amram E; Rinott G; Koifman G; Fishman S; Keisari Y; Tzehoval E; Margalit A; Eisenbach L; Gross G
    Int Immunol; 2011 Jul; 23(7):453-61. PubMed ID: 21652516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural elements of a protein antigen determine immunogenicity of the embedded MHC class I-restricted T cell epitope.
    Paster W; Kalat M; Zehetner M; Schweighoffer T
    J Immunol; 2002 Sep; 169(6):2937-46. PubMed ID: 12218107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulin.
    Cafri G; Margalit A; Tzehoval E; Eisenbach L; Gross G
    Ann N Y Acad Sci; 2013 Apr; 1283():87-90. PubMed ID: 23387369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells.
    Benoit LA; Tan R
    J Immunol; 2007 Sep; 179(6):3588-95. PubMed ID: 17785793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.